This course has expired. View available courses.
Endocrinology
Clinical Type 2 Diabetes Review: Intensification Beyond First-lineTherapy – Royal College of General Practitioners
DURATION
PROFESSION
# OF CREDITS
0.25
ACCREDITATION
EXPIRY DATE
2020-05-27
Faculty
Peter J. Lin (MD, CCFP), Filip K. Knop (MD, PhD), David C.W. Lau (MD, PhD, FRCPC), Thomas Round (MBBS, BSc, DRCOG, MRCGP), David Strain (MBChB, MD, FRCP), Elizabeth Rosolowsky (MD, MPH, FAAP, FRCPC), Robyn L. Houlden (MD, FRCPC), John Axler (MD, CCFP, FCF
Learning objectives
Upon completion of this program, participants will be able to:
- Review the key considerations for selecting an antihyperglycemic agent after metformin therapy
- Examine the impact of cardiovascular disease and patient preference on antihyperglycemic agent selection